Internal Nasal Dilators Market Size, Share, and Industry Analysis, By Design (Smooth, Ribbed, and Others), By Material (Silicone, Plastic, and Others), By Size (Small, Medium, and Large), By Application (Obstructive Sleep Apnea (OSA), Asthma, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

The global internal nasal dilators market is experiencing rapid expansion that is facilitated by the ongoing technological advancements that enhance the nasal valve airflow. These dilators are utilized to address nasal congestion or obstruction, known to cause snoring and other nasal breathing difficulties. By expanding and exerting gentle pressure on the nasal passages, these devices widen the nostrils, diminish nasal resistance, and offer relief to individuals afflicted by obstructive sleep apnea syndrome (OSAS). The rising global prevalence of sleep and respiratory disorders, including obstructive sleep apnea and asthma, is also fostering the demand for internal nasal dilators.

• According to a 2021 article published by the Journal of Clinical Medicine, there are more than one billion people globally affected by obstructive sleep apnea and the prevalence exceeded 50% in some countries.

Internal Nasal Dilators Market Driver

Growing Prevalence of Sleep Disorders to Fuel Market Demand

More than half of the population is impacted by snoring and approximately one-third of the individuals have been diagnosed with a sleep disorder that disrupts their sleep quality. This has led to the increasing demand for nasal dilators.

• According to a 2023 article published by Sleep Review, approximately 57% of individuals experience snoring, and an additional 10% reported other sleep disorders. These disorders include parasomnias, circadian rhythm disorders, and central sleep apnea.

Download Free sample to learn more about this report.

According to an article published by the American Thoracic Society (ATS) Journal, the prevalence of Obstructive Sleep Apnea (OSA) ranges from 0.9 million to 95.9 million in adults aged 18 years to 90 years in key countries in 2021.

Internal Nasal Dilators Market Restraint

Availability of Alternative Treatment Options to Hamper Product Adoption 

In certain instances, nasal surgery can serve as a viable treatment for conditions such as snoring and sleep apnea. It has the potential to alleviate symptoms such as sleepiness and respiratory disturbances, which may hinder the adoption of internal nasal dilators in the market.

• According to a 2023 report published by the International Society of Aesthetic Plastic Surgery (ISAPS) there were around 1.2 million rhinoplasty surgeries globally in 2023, witnessing a growth of around 21.6% compared to the previous year. This suggests a growing number of individuals choosing to undergo surgery procedures for cosmetic or medical reasons.

Internal Nasal Dilators Market Opportunity

Increasing Launches of Innovative Devices to Foster Market Growth

The internal nasal dilators market is seeing substantial growth due to the emergence of new devices that can provide the improved ease of use, comfort, and adaptability for patients of various types.

• According to a publication on ResearchGate in January 2024, it was reported that nasal dilators have been shown to augment athletic performance by improving the nasal airflow, which in turn enhances oxygen uptake. The specific nasal dilator, Nas-Air, was highlighted for its significant impact on reducing the perception of fatigue, potentially contributing to prolonged endurance and improved overall athletic output.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Disorders, By Key Countries 2023
• Overview: Technological Advancements in Internal Nasal Dilators
• Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• New Product Launches, By Key players
• Impact of COVID-19 on the Market

Analysis by Design

Based on design, the market is subdivided into smooth, ribbed, and others.

The ribbed segment accounts for a substantial market share in 2023. The wide utilization of ribbed internal nasal dilators is due to their enhanced comfort and better support. The increasing demand for nasal dilators emphasizes the importance of developing convenient and efficient devices.

• In October 2022, DIMEDI KOREA introduced Goyozam Z-01, an internal nasal dilator with a ribbed design. This innovative feature serves to optimize airflow, specifically addressing the needs of individuals with slotted nostrils, offering significant improvements in nasal breathing function.

Analysis by Material

By material, the market is segmented into silicone, plastic, and others.

The silicone segment accounts for a prominent share of the market, primarily due to its exceptional properties. This type of material is latex-free, BPA-free, and phthalate-free, making it safe for usage. It is specifically designed to cause no irritation or allergic reactions and does not contain any adhesive, making it ideal for a wide range of medical applications. 

• In 2024, Woodyknows introduced two new devices to its product line: the Super Support 2024 Standard and the Super Support 2024 Soft. Both of these devices are made from medical-grade silicone, which is classified under the soft polymer category. They are designed to provide exceptional support and comfort for users in medical applications.

Analysis by Size

By size, the market is fragmented into small, medium, and large.

The medium segment accounts for a robust share in the global market. The rising preference of medium-sized internal nasal dilators among the population due to their comfortable fit and convenient size is expected to fuel the segment growth. The market is seeing a notable increase in the demand for dilators that provide a snug fit without causing discomfort, which is driving market growth.

• According to an article published by MDPI in 2022, various internal nasal dilators were compared, which revealed that the majority of individuals showed a preference for a medium-sized nasal dilator that offered a comfortable fit.

Analysis by Application

By application, the market is divided into obstructive sleep apnea (OSA), asthma, and others.

The obstructive sleep apnea (OSA) segment accounted for a significant market share in 2023. The rising prevalence of OSA among the population along with increasing awareness regarding the benefits of nasal dilators for management are some of the major factors contributing to the segment growth.

• According to a May 2022 article published by the National Institutes of Health (NIH), a study on the prevalence of obstructive sleep apnea (OSA) in the general population found that 24% of men and 9% of women were affected by moderate OSA.

Analysis by Distribution Channel

Based on distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies.

The online pharmacies segment is projected to grow at the fastest CAGR over the forecast period. The dominance of the segment is attributed to the emergence of digital pharmacies, also known as mail-order or online pharmacies. The substantial growth of these pharmacies can be attributed to the integration of convenience and the increasing need for their services.

• In October 2022, PharmaNewsIntelligence published an article indicating that approximately 25% of respondents identified improved access as the most significant advantage of online pharmacies. Additionally, 23% and 10% of survey participants cited convenience and discounted product rates, respectively, as the primary benefits of online pharmacies.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market for internal nasal dilators has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominated the market in 2023. The growing prevalence of sleep apnea and other sleep disorders among the population in the U.S. and Canada along with the growing adoption of nasal dilators are some of the key factors supporting the regional expansion.

• According to a 2024 article published by the National Council on Aging (NCOA), nearly 39 million adults in the U.S. have obstructive sleep apnea (OSA). Further, around 56% of the population aged 65 years and above have a high risk of developing the condition.

The rising prevalence of obstructive sleep apnea (OSA) among the population in the U.K., Germany, France, and other European countries along with growing number of diagnosis of the condition among the population are some of the significant factors favoring the product demand. These devices are being increasingly used to manage these conditions.

• According to a 2022 article published by the Sleep Apnoea Trust, nearly 3.9 million people in the U.K. had moderate to severe obstructive sleep apnea (OSA) and around 6.0 million people had mild OSA in 2019.

The rising focus of national organizations, healthcare providers in various Asian countries to spread awareness and support the utilization of nasal dilators among the population suffering from various sleep disorders is set to drive regional expansion. Another factor fostering industry expansion comprises the growing patient population with diagnosed sleep disorders.

• A June 2023 study by PubMed analyzed 33,353 individuals and found that the overall prevalence of obstructive sleep apnea (OSA) in older adults was 35.9%. A subgroup analysis revealed the highest prevalence in the Asian continent at 37.0%.

Key Players Covered

The global internal nasal dilators market is fragmented, with the presence of a large number of prominent players.

• Rhinomed Limited (Australia)
• Splintek, Inc. (U.S.)
• THE OXYGEN ADVANTAGE (Ireland)
• Quest Products, LLC. (U.S.)
• M&M Pure Air System LLC (U.S.)
• Mckeon (U.S.)
• ZQuiet (U.S.)
• Nasilator (U.S.)
• NASDIL (U.S.)
• EP MEDICA srl (Italy)

Key Industry Developments

• In March 2024, Splintek, Inc. made a groundbreaking announcement about their latest innovation, the SleepRight Intra-Nasal Breathe Aid. This new product is set to transform the way people experience breathing and is anticipated to have a significant impact on the market.

• In 2021, Mute's innovative anti-snoring device was recognized and featured in the Health Sleep Awards. Their product secured a well-deserved place on the prestigious list of best Snoring Aides.